Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) 3-Year EBITDA Growth Rate : 73.20% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Gansu Longshenrongfa Pharmaceutical Industry Co 3-Year EBITDA Growth Rate?

Gansu Longshenrongfa Pharmaceutical Industry Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.12.

During the past 12 months, Gansu Longshenrongfa Pharmaceutical Industry Co's average EBITDA Per Share Growth Rate was 4.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 73.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 30.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -4.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Gansu Longshenrongfa Pharmaceutical Industry Co was 73.20% per year. The lowest was -32.10% per year. And the median was -4.65% per year.

Competitive Comparison of Gansu Longshenrongfa Pharmaceutical Industry Co's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Gansu Longshenrongfa Pharmaceutical Industry Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gansu Longshenrongfa Pharmaceutical Industry Co's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gansu Longshenrongfa Pharmaceutical Industry Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Gansu Longshenrongfa Pharmaceutical Industry Co's 3-Year EBITDA Growth Rate falls into.

Gansu Longshenrongfa Pharmaceutical Industry Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Gansu Longshenrongfa Pharmaceutical Industry Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Gansu Longshenrongfa Pharmaceutical Industry Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gansu Longshenrongfa Pharmaceutical Industry Co Ltd (SZSE:300534) » Definitions » 3-Year EBITDA Growth Rate

Traded in Other Exchanges

N/A

Address

No. 10, Defence Road, Dingyuan Town, Gansu Province, Lanzhou, CHN, 730101

Website

http://www.lsrfzy.com

Gansu Longshenrongfa Pharmaceutical Industry Co Ltd is mainly engaged in the pharmaceutical business. It is engaged in the research and development of new drugs, traditional Chinese medicine processing and production. Its products portfolio includes Yuan Hu Zhitong Dripping Pills, Qiwei Wenyang Capsule and Xiaoshuan Tongluo Tablets. Its products are used to adjust gas, promote blood circulation, relieve pain, relieve cough, eliminate phlegm, relieve asthma, clear heat, and dispel dampness, among others.

Executives

Chen Yao Wu	Executives
Zhang Jin De	Director
Zhang Fan	Executives
Kong Jian Feng	Executives
Yue Qing Xin	Supervisors
Kang Yong Hong	Executives

Gansu Longshenrongfa Pharmaceutical Industry Co (SZSE:300534) Headlines

No Headlines